A new approach to drug delivery.


285 million people are estimated to be visually impaired worldwide, 39 million of which are completely blind. Globally, uncorrected refractive errors are the main cause of visual impairment followed by cataracts and glaucoma. 80% of all visual impairment can be avoided or cured (WHO).

LayerBio is developing novel drug delivery strategies for treatment of eye disease. Topical eye drops are the typical method for delivery of medication to the eye, but they have limitations with respect to patient compliance and inability to adequately penetrate deeply into the eye. Alternative delivery strategies are needed to improve therapies for patients with eye disease, and LayerBio is developing novel solutions to address this important problem.